New US FDA Generics Director Praises Industry, Encourages Partnerships
Executive Summary
Refuse-to-receive rates for ANDAs are down, suggesting sponsors better understand the standards for quality applications, Office of Generic Drugs Director Sally Choe says in first speech to industry.